Session 2: Health and Quality of Life
Moderator: Thomas Goetz, Deputy Editor, Wired Magazine
The Promise of Synthetic Biology
Jay Keasling, Professor, Chemical Engineering and Bioengineering, University of California, Berkeley
Cost-Effective and Personalized Healthcare
Regis “Reg” Kelly, Director, California Institute for Quantitative Biomedical Research (QB3)
Paul Camuti, President and CEO, Siemens Corporate Research Center
The New War on Cancer
Frank Douglas, Senior Fellow, Kauffman Foundation
Irving Weissman, Director, Institute of Stem Cell Biology and Regenerative Medicine, Stanford University
http://tls.berkeley.edu/GTLconference.html
Add A Comment